Teens may also get a MenB vaccine , preferably at 16 through 18 years old. Even if you received meningococcal vaccines, you could still get meningococcal disease. While any teen may choose to get a MenB vaccine, certain preteens and teens should get it if they:.
Meningococcal Vaccines for Preteens and Teens pdf icon [1 page] This fact sheet answers general questions about meningococcal vaccines for preteens and teens. Get more information about meningococcal vaccine recommendations for teenagers: Meningococcal Vaccination for Preteens and Teens: Information for Parents.
Because of age or health conditions, some people should not get certain vaccines or should wait before getting them. Tell the person who is giving you or your child a meningococcal vaccine if:. This immune response suggests the vaccines provide protection, but data are limited on how well they work. Since meningococcal disease is uncommon, many people need to get these vaccines in order to measure their effectiveness.
Getting the year-old MenACWY booster dose is critical so teens have protection when they are most at risk for meningococcal disease. Available data on MenB vaccines suggest that protective antibodies also decrease quickly within 1 to 2 years after vaccination.
Rates of meningococcal disease have declined in the United States since the s and remain low today. In addition, serogroup B meningococcal disease declined even though MenB vaccines were not available until the end of These data suggest MenACWY vaccines have provided protection to those vaccinated, but probably not to the larger, unvaccinated community population or herd immunity.
Experts also believe MenB vaccines do not provide protection to unvaccinated people through population immunity. Most people who get a meningococcal vaccine do not have any serious problems with it. Both vaccines can prevent 4 types of meningococcal disease, including 2 of the 3 types most common in the United States and a type that causes epidemics in Africa. Meningococcal vaccines cannot prevent all types of the disease.
But they do protect many people who might become sick if they didn't get the vaccine. MCV4 is expected to give better, longer-lasting protection. This dose is normally given during the routine preadolescent immunization visit at years. But those who did not get the vaccine during this visit should get it at the earliest opportunity. Meningococcal vaccine is also recommended for other people at increased risk for meningococcal disease:. MCV4 is the preferred vaccine for people 2 through 55 years of age in these risk groups.
People 2 years of age and older should get 1 dose. Sometimes a second dose is recommended for people who remain at high risk. Ask your provider. MPSV4 may be recommended for children 3 months to 2 years of age under special circumstances. These children should get 2 doses, 3 months apart. A vaccine, like any medicine, could possibly cause serious problems, such as severe allergic reactions.
The risk of meningococcal vaccine causing serious harm, or death, is extremely small. As many as half the people who get meningococcal vaccines have mild side effects, such as redness or pain where the shot was given.
If these problems occur, they usually last for 1 or 2 days. A small percentage of people who receive the vaccine develop a fever. A federal program exists to help pay for the care of anyone who has had a rare serious reaction to a vaccine. For information about the National Vaccine Injury Compensation Program, call or visit their website at www.
Meningococcal vaccine What You Need to Know 1. What is Meningococcal disease? Meningococcal disease also causes blood infections. Echols Board of Health meeting will be Turner Board of Health meeting will be Tift Board of Health meeting will be Ben Hill Board of Health meeting will Vaccination, with other preventive measures, can protect Notice: JavaScript is required for this content.
Posted: May 25, by Kristin Patten.
0コメント